TY - JOUR
T1 - Study on the molecular pathogenesis of human papillomavirus (HPV)-related squamous cell carcinoma of the tongue-base region and tonsil
AU - Kato, Hisayuki
AU - Yui, Takehiro
AU - Okada, Tatsuyoshi
AU - Sakurai, Kazuo
AU - Yamamoto, Naoki
PY - 2010
Y1 - 2010
N2 - We investigated the prevalence of high-risk human papillomavirus (HR-HPV) in squamous cell carcinoma of the tonsil and tongue-base region, and evaluated its clinical features and prognostic implications according to HPV status and p16 and p53 expression. HR-HPV was positive in 16 (53%) of 30 samples. Of these positive cases, 15 (94%) carried HPV 16 sequences and only 1 (6%) carried a HPV58 sequence. Among the HPV-positive patients, the frequency of heavy smokers and drinkers was significantly lower than among the HPV-negative patients. Among the 30 patients, p16 was overexpressed in 16 (53%), and this overexpression was strongly associated with the presence of HR-HPV (P < 0.0001). In contrast, HPV-negative patients were more likely to have p53 overexpression (75%). On univariate analysis, both HPV-positive status (86% vs. 48%; P = 0.029) and p16 overexpression (100% vs. 31%; P < 0.001) significantly improved the overall survival (OS), respectively. On the other hand, p53 overexpression was significantly associated with inferior OS (42% vs. 83%; P = 0.004). These results indicate that it will be necessary to use these HPV-related biomarkers for decisions on staging and therapeutic strategy.
AB - We investigated the prevalence of high-risk human papillomavirus (HR-HPV) in squamous cell carcinoma of the tonsil and tongue-base region, and evaluated its clinical features and prognostic implications according to HPV status and p16 and p53 expression. HR-HPV was positive in 16 (53%) of 30 samples. Of these positive cases, 15 (94%) carried HPV 16 sequences and only 1 (6%) carried a HPV58 sequence. Among the HPV-positive patients, the frequency of heavy smokers and drinkers was significantly lower than among the HPV-negative patients. Among the 30 patients, p16 was overexpressed in 16 (53%), and this overexpression was strongly associated with the presence of HR-HPV (P < 0.0001). In contrast, HPV-negative patients were more likely to have p53 overexpression (75%). On univariate analysis, both HPV-positive status (86% vs. 48%; P = 0.029) and p16 overexpression (100% vs. 31%; P < 0.001) significantly improved the overall survival (OS), respectively. On the other hand, p53 overexpression was significantly associated with inferior OS (42% vs. 83%; P = 0.004). These results indicate that it will be necessary to use these HPV-related biomarkers for decisions on staging and therapeutic strategy.
UR - http://www.scopus.com/inward/record.url?scp=85009643535&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85009643535&partnerID=8YFLogxK
U2 - 10.5981/jjhnc.36.339
DO - 10.5981/jjhnc.36.339
M3 - Article
AN - SCOPUS:85009643535
SN - 1349-5747
VL - 36
SP - 339
EP - 343
JO - Toukeibu Gan
JF - Toukeibu Gan
IS - 3
ER -